Prosaposin hyperglycosylation: a novel tumor immune escape mechanism and implications for cancer immunotherapy by Matthias Peipp, Diana Dudziak, Christian Kellner

Get full text

Editorial: Effector functions of therapeutic antibodies by Peter Boross, Matthias Peipp, Falk Nimmerjahn

Get full text

Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks <i>in vivo</i> tumor growth by Renate Burger, Anna Otte, Jan Brdon, Matthias Peipp, Martin Gramatzki

Get full text

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression by Oanh T. P. Nguyen, Sandra Lara, Giovanni Ferro, Matthias Peipp, Sandra Kleinau

Get full text

Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity by Daniel Gonnermann, Hans-Heinrich Oberg, Marcus Lettau, Matthias Peipp, Dirk Bauerschlag, Susanne Sebens, Dieter Kabelitz, Daniela Wesch

Get full text

Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies by Arturo Macarrón Palacios, Julius Grzeschik, Lukas Deweid, Simon Krah, Stefan Zielonka, Thies Rösner, Matthias Peipp, Thomas Valerius, Harald Kolmar

Get full text

Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3 by Jan Schadeck, Hans-Heinrich Oberg, Matthias Peipp, Nina Hedemann, Wolfgang W. Schamel, Wolfgang W. Schamel, Dirk Bauerschlag, Daniela Wesch

Get full text

Enhanced ADCC activity of affinity maturated and Fc-engineered mini-antibodies directed against the AML stem cell antigen CD96. by Sahar Mohseni Nodehi, Roland Repp, Christian Kellner, Joachim Bräutigam, Matthias Staudinger, Natalie Schub, Matthias Peipp, Martin Gramatzki, Andreas Humpe

Get full text

Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth by Renate Burger, Andreas Günther, Katja Klausz, Matthias Staudinger, Matthias Peipp, Eva Maria Murga Penas, Stefan Rose-John, John Wijdenes, Martin Gramatzki

Get full text

Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy by Katja Klausz, Michael Cieker, Christian Kellner, Thies Rösner, Anna Otte, Steffen Krohn, Anja Lux, Falk Nimmerjahn, Thomas Valerius, Martin Gramatzki, Matthias Peipp

Get full text

Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific Antibodies by Steffen Krohn, Tosca Holtrop, Arianne M. Brandsma, Petra Moerer, Maaike Nederend, Nikos Darzentas, Monika Brüggemann, Katja Klausz, Jeanette H. W. Leusen, Matthias Peipp

Get full text

424 Adoptive cell therapy with cytokine-induces killer cells armed with immunotools against Her-2 expressing breast cancer by Gaia Griguolo, Anna Dalla Pietà, Elisa Cappuzzello, Annavera Ventura, Roberta Sommaggio, Antonio Rosato, Hieu Trong Ngo, Emilia Vigolo, Giulia D’Accardio, Sara Perpinello, Matthias Peipp

Molecular Mechanisms by Which a Fucus vesiculosus Extract Mediates Cell Cycle Inhibition and Cell Death in Pancreatic Cancer Cells by Ulf Geisen, Marion Zenthoefer, Matthias Peipp, Jannik Kerber, Johannes Plenge, Antonella Managò, Markus Fuhrmann, Roland Geyer, Steffen Hennig, Dieter Adam, Levent Piker, Gerald Rimbach, Holger Kalthoff

Get full text

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells by Doaa Tawfik, Christopher Groth, Christopher Groth, Jan-Paul Gundlach, Jan-Paul Gundlach, Matthias Peipp, Dieter Kabelitz, Thomas Becker, Hans-Heinrich Oberg, Anna Trauzold, Anna Trauzold, Daniela Wesch

Get full text

1005 BiXAb® MAIT Engagers: solving the problems of classical T-cell engagers in the treatment of solid tumors by Claire Germain, Matthias Peipp, Simon E Plyte, Marie Fraudeau, Dorothee Winterberg, Camille Rousseau, Gaetano Sodaro, Maxime Audin, Alexandre Ivagnes, Hans Heinrich Oberg, Pierre Emmanuel Gerard, Daniela Wesch, Julie Prigent

Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display by Steffen Krohn, Ammelie Svea Boje, Carina Lynn Gehlert, Sebastian Lutz, Nikos Darzentas, Henrik Knecht, Dietrich Herrmann, Monika Brüggemann, Axel J. Scheidig, Katja Weisel, Martin Gramatzki, Matthias Peipp, Katja Klausz

Get full text

Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations in vivo by Anja Schaffert, Maja Hanić, Mislav Novokmet, Olga Zaytseva, Jasminka Krištić, Anja Lux, Lars Nitschke, Matthias Peipp, Marija Pezer, René Hennig, René Hennig, Erdmann Rapp, Erdmann Rapp, Gordan Lauc, Gordan Lauc, Falk Nimmerjahn

Get full text

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering by Sophia Roßkopf, Klara Marie Eichholz, Dorothee Winterberg, Katarina Julia Diemer, Sebastian Lutz, Ira Alexandra Münnich, Katja Klausz, Thies Rösner, Thomas Valerius, Denis Martin Schewe, Andreas Humpe, Martin Gramatzki, Matthias Peipp, Christian Kellner

Get full text

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab by Niklas Baumann, Christian Arndt, Judith Petersen, Marta Lustig, Thies Rösner, Katja Klausz, Christian Kellner, Miriam Bultmann, Lorenz Bastian, Fotini Vogiatzi, Jeanette H. W. Leusen, Renate Burger, Denis M. Schewe, Matthias Peipp, Thomas Valerius

Get full text

Enhanced potency of immunotherapy against B‐cell precursor acute lymphoblastic leukemia by combination of an Fc‐engineered CD19 antibody and CD47 blockade by Denis M. Schewe, Fotini Vogiatzi, Ira A. Münnich, Tobias Zeller, Roland Windisch, Christian Wichmann, Kristina Müller, Hilal Bhat, Elisa Felix, Dimitrios Mougiakakos, Heiko Bruns, Lennart Lenk, Thomas Valerius, Andreas Humpe, Matthias Peipp, Christian Kellner

Get full text